202 related articles for article (PubMed ID: 29751149)
1. An inhibitor of soluble epoxide hydrolase ameliorates diabetes-induced learning and memory impairment in rats.
Minaz N; Razdan R; Hammock BD; Goswami SK
Prostaglandins Other Lipid Mediat; 2018 May; 136():84-89. PubMed ID: 29751149
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
4. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
5. Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.
Ren Q; Ma M; Ishima T; Morisseau C; Yang J; Wagner KM; Zhang JC; Yang C; Yao W; Dong C; Han M; Hammock BD; Hashimoto K
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):E1944-52. PubMed ID: 26976569
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
[TBL] [Abstract][Full Text] [Related]
7. Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern.
Ostermann AI; Herbers J; Willenberg I; Chen R; Hwang SH; Greite R; Morisseau C; Gueler F; Hammock BD; Schebb NH
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt A):131-7. PubMed ID: 26117215
[TBL] [Abstract][Full Text] [Related]
8. Lack of rewarding effects of a soluble epoxide hydrolase inhibitor TPPU in mice: Comparison with morphine.
Wan X; Fujita Y; Chang L; Wei Y; Ma L; Wuyun G; Pu Y; Hammock BD; Hashimoto K
Neuropsychopharmacol Rep; 2020 Dec; 40(4):412-416. PubMed ID: 32896112
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
10. 1-trifluoromethoxyphenyl-3(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor attenuates high fat diet-induced cardiovascular and metabolic disorders in rats.
Bukhari IA; Mohamed OY; Mahmood A; Alfadda AA; Almotrefi AA
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(10):3835-3847. PubMed ID: 34109592
[TBL] [Abstract][Full Text] [Related]
11. TPPU, a sEH Inhibitor, Attenuates Corticosterone-Induced PC12 Cell Injury by Modulation of BDNF-TrkB Pathway.
Wu Q; Song J; Meng D; Chang Q
J Mol Neurosci; 2019 Mar; 67(3):364-372. PubMed ID: 30644034
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol-Induced Cardiac Fibrosis by Restoring Autophagic Flux.
Zhou C; Huang J; Li Q; Zhan C; He Y; Liu J; Wen Z; Wang DW
Alcohol Clin Exp Res; 2018 Oct; 42(10):1970-1978. PubMed ID: 30047995
[TBL] [Abstract][Full Text] [Related]
13. A Soluble Epoxide Hydrolase Inhibitor, 1-TrifluoromethoxyPhenyl-3-(1-Propionylpiperidin-4-yl) Urea, Ameliorates Experimental Autoimmune Encephalomyelitis.
Jonnalagadda D; Wan D; Chun J; Hammock BD; Kihara Y
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925035
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.
Goswami SK; Rand AA; Wan D; Yang J; Inceoglu B; Thomas M; Morisseau C; Yang GY; Hammock BD
Life Sci; 2017 Jul; 180():114-122. PubMed ID: 28522175
[TBL] [Abstract][Full Text] [Related]
15. Soluble epoxide hydrolase inhibitor mediated analgesia lacks tolerance in rat models.
Wagner KM; Atone J; Hammock BD
Brain Res; 2020 Feb; 1728():146573. PubMed ID: 31790682
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Target-Mediated Drug Disposition Model for Two Small-Molecule Compounds Competing for Their Pharmacological Target: Soluble Epoxide Hydrolase.
Wu N; Hammock BD; Lee KSS; An G
J Pharmacol Exp Ther; 2020 Jul; 374(1):223-232. PubMed ID: 32238455
[TBL] [Abstract][Full Text] [Related]
17. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
Bukhari IA; Alorainey BI; Al-Motrefi AA; Mahmoud A; Campbell WB; Hammock BD
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8143-8150. PubMed ID: 32767352
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of sEH via stabilizing the level of EETs alleviated Alzheimer's disease through GSK3β signaling pathway.
Sun CP; Zhang XY; Zhou JJ; Huo XK; Yu ZL; Morisseau C; Hammock BD; Ma XC
Food Chem Toxicol; 2021 Oct; 156():112516. PubMed ID: 34411643
[TBL] [Abstract][Full Text] [Related]
19. The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs.
Froogh G; Kandhi S; Duvvi R; Le Y; Weng Z; Alruwaili N; Ashe JO; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H985-H993. PubMed ID: 32167781
[TBL] [Abstract][Full Text] [Related]
20. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]